ALPS Advisors’s BioSpecifics Technologies Corp. BSTC Stock Holding History

ALPS Advisors’s Portfolio BSTC Stock Details BSTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-4,064	Closed	-$249K	–	967
2020 Q2	$249K	Sell	4,064 -450	-10%	-$26K	﹤0.01%	652
2020 Q1	$255K	Buy	+4,514	New	+$257K	﹤0.01%	556
2019 Q3	–	Sell	-5,522	Closed	-$330K	–	1034
2019 Q2	$330K	Sell	5,522 -292	-5%	-$18.4K	﹤0.01%	824
2019 Q1	$362K	Buy	+5,814	New	+$385K	﹤0.01%	848
2016 Q1	–	Sell	-9,395	Closed	-$404K	–	790
2015 Q4	$404K	Hold	9,395	–	–	﹤0.01%	600
2015 Q3	$4.09K	Buy	+9,395	New	+$507K	﹤0.01%	621

Other funds holding BSTC

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

ALPS Advisors's BSTC Position: Q3 2020 in Review

ALPS Advisors sold out of BioSpecifics Technologies Corp. (BSTC) in Q3 2020, closing a stake of 4,064 shares — an estimated $249K sold.

ALPS Advisors first reported a position in BSTC in Q3 2015 and held it in 6 quarters. The position peaked at $404K in Q4 2015. 113 funds tracked by Wall St. Rank hold BSTC as of Q3 2020.

ALPS Advisors reported no remaining BioSpecifics Technologies Corp. position as of Q3 2020 after selling out during the quarter.
ALPS Advisors sold 4,064 BioSpecifics Technologies Corp. shares in Q3 2020, an estimated $249K.
ALPS Advisors first reported a position in BioSpecifics Technologies Corp. in Q3 2015 and held it in 6 quarters.
ALPS Advisors's BioSpecifics Technologies Corp. position peaked at $404K in Q4 2015.
113 funds tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q3 2020.

Based on ALPS Advisors's 13F filing for Q3 2020, filed 4 Nov 2020.